dotMD.com
✓ Translated by DotMD AI Clinical Council Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology • Phase III Randomized Trial
Verify Primary Source: NIH PubMed PMID #39395667
Plain-English Research Story • 8th-Grade Reading Level

New Insights on Breast induration and irradiated volume in the DBCG HYPO trial: The impact of: What a 343-Participant Study Found

A relationship between irradiated breast volume and 3-year frequency of breast induration was found for patients ≥ 65 years, whilst not for patients aged 50-64 years..

Original Paper Title: “Breast induration and irradiated volume in the DBCG HYPO trial: The impact of age, smoking, and boost” (Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2024-12-15)

Elena Rostova (AI Quant) Rigor Score
87 / 100
Sample Size (Participants)
N = 343
Evidence Classification
Phase III Randomized Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • The Bottom-Line Finding: A relationship between irradiated breast volume and 3-year frequency of breast induration was found for patients ≥ 65 years, whilst not for patients aged 50-64 years..
  • Who Was Studied: Phase III Randomized Trial published in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology following 343 real-world participants.
  • Strength of the Evidence: Earned a 87/100 Study Rigor Score based on trial design, sample size, and peer-reviewed controls.
  • Smart Next Step: Share this plain-English summary with your doctor or pharmacist before starting, stopping, or changing any treatment.
The Full Story in Plain English

What the Study Found (In Plain English)

Why This Matters to You

Journal of the European Society for Therapeutic Radiology and Oncology (2024), this phase iii randomized trial evaluating 343 human participants investigated: To investigate the association between irradiated breast volume and grade 2-3 breast induration three years after radiotherapy in the phase III Danish Breast Cancer Group HYPO trial randomizing patients ≥ 41 years to whole breast irradiation (WBI) with 40 Gy/15fr versus 50 Gy/25fr. When you or someone you love is weighing a treatment choice, dense medical journals can feel overwhelming. Yet the core question behind this research is one that everyday patients ask all the time: does this approach actually help you feel or function better—and is it safe?

How the Study Worked

To find out, researchers writing in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology conducted a phase iii randomized trial evaluating 343 real-world participants. Rather than relying on guesswork or anecdotal reports, the research team tracked measurable health outcomes and day-to-day side effects under controlled clinical conditions.

What the Study Found in Plain English

A relationship between irradiated breast volume and 3-year frequency of breast induration was found for patients ≥ 65 years, whilst not for patients aged 50-64 years.. Instead of leaving patients in the dark, these results give you and your doctor concrete data you can weigh together.

The Catch: What to Keep in Mind

Even strong medical studies have limits. Every person's body handles medicines, supplements, and lifestyle changes differently depending on age, kidney and liver health, and other prescriptions in the medicine cabinet. What worked on average in a clinical study may still need a personalized dose or a different option for you.

Bottom Line: Your Next Step

Bring this summary to your next doctor or pharmacist visit. Ask: "Based on my health history and current medications, does this research apply to me?" You can also click the formal study link below to inspect the original peer-reviewed paper directly.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Published in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (2024-12-15) • Study Design: Phase III Randomized Trial • Participants: N = 343 • Biostatistical Rigor Score: 87/100. Primary Takeaway: A relationship between irradiated breast volume and 3-year frequency of breast induration was found for patients ≥ 65 years, whilst not for patients aged 50-64 years..

Study Limitations & Caveats Before You Act

While this phase iii randomized trial scored 87/100 for research quality, clinical trials follow strict rules that may not match every patient's daily life. Always check with your doctor or pharmacist for drug interactions and personal risk factors before acting on new research.

Formal Peer-Reviewed Study Reference
“Breast induration and irradiated volume in the DBCG HYPO trial: The impact of age, smoking, and boost”
Published in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (2024-12-15) • PMID/ID: 39395667
Read Formal Study

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 39395667: New Insights on Breast induration and irradiated volume in the DBCG HYPO trial: The impact of: What a 343-Participant Study Found

3 of 3 Free Questions Remaining